Following Johnson & Johnson’s record $2.2 billion settlement for criminal marketing — including $1.4 billion related to its marketing of Risperdal, making it one of the largest fraud settlements involving a single drug — two academics who contributed to an article that helped sell the drug are expressing concerns about their participation. The paper included an error that cut young boys’ projected risk of developing breasts by half.
Oh, so now they’re concerned after all the damage has been done to countless numbers of people! A little late in my estimate! If you hang with the dogs then you’re going to get fleas, just stands to reason. They need to take their drubbing that they justly deserve without trying to get out of anything.
Report comment
Does NAMI have anything to say about the Risperdal lawsuit ? The “National Alliance For The Mentally Ill” was pushing the use of Risperdal off label in children. NAMI had this link posted on their website HOME PAGE . “Risperidone for Adolescent Aggression” Medical Focus, Winter 1996
http://web.archive.org/web/19961221104126/http://www.nami.org/
Report comment
All the academics that have never looked through the eyes of psychosis are clueless anyway, they have never seen that world that the ‘mentally ill’ know about, live in, visited or traveled through.
I got one thing to say to the “academics” , you want to write about a drug take a few doses YOURSELF so you know WTF your writing about otherwise STFU.
Report comment
Well said _cat !
Report comment